相关实验视频

Updated: Jan 15, 2026

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

多主题门德尔的随机化和单细胞分析确定了骨髓缩症的新型治疗点

Jiyong Yang¹, Miaoling Gong¹, Yi Zhou¹

¹The Fifth Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510095, Guangdong, China.

The journals of gerontology. Series A, Biological sciences and medical sciences

|October 10, 2025

概括

这项研究确定了骨质沙症的潜在治疗点,这种疾病影响着老龄化人口. 像MGP和CTSS这样的关键基因显示出保护作用,而ART4和MMP16可能会增加风险,指导未来的骨髓缩症管理.

科学领域:

遗传学和衰老研究研究
分子生物学分子生物学
药物基因组学药物基因组学

背景情况:

骨质疏松症和骨质疏松症的同时存在的骨质疏松症和骨质疏松症,对全球老龄化人口造成重大健康负担.
确定新的治疗点对于管理这种复杂的疾病至关重要.

研究的目的:

为了精确地确定骨髓缩症的潜在治疗点.
为了利用多omics 门德尔随机化 (MR) 和单细胞RNA测序 (scRNA-seq) 进行目标识别.

主要方法:

综合性分析包括转录组范围MR,基于摘要的MR (SMR) 和同位分析.
利用了大规模的全基因组关联研究 (GWAS) 对血转录组和蛋白质组的数据.
通过使用scRNA-seq.使用各种组织和细胞类型检查的候选点基因表达.

主要成果:

在多个数据集中,MRI分析揭示了331个基因和44个蛋白质与骨质疏松症特征有因果关系.
12个因果目标得到了一致的验证,MGP,CTSS和SNUPN被确定为保护因素.
MMP16,ART4和PSMD9与骨质缩症风险增加有关;MGP和CTSS显示对肌肉骨系统有潜在的直接影响.

结论:

建议ART4,MMP16和PSMD9作为骨髓缩症的危险因素.
MGP,SNUPN和CTSS表明在骨髓缩症中具有潜在的保护作用.
需要进一步的研究来验证这些目标,并阐明它们在骨髓缩症的发病和治疗中的具体作用.

关键词:

骨肌单位是一个骨肌单位.因果推理的原因推理.药物门德尔的随机化药物门德尔的随机化多个omics的多个omics.单细胞测序是一种单细胞测序.

更多相关视频

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Author Spotlight: Exploring Advanced Therapeutic Targets in Osteosarcoma Through Spatial Transcriptomics

Published on: May 3, 2024

相关概念视频

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...